Obesity
Conditions
Brief summary
The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of red ginseng on decrement of body fat. The investigators measured decrement of body fat parameters , including Body Fat Mass, Percent Body Fat, weight and BMI(body mass index), and monitored their blood pressure.
Interventions
Red Ginseng (1.4g/day)
Placebo (1.4g/day)
Sponsors
Study design
Eligibility
Inclusion criteria
* Males and females 19-65 years old * BMI(body mass index) ≥ 25 kg/m\^2 or WC(Waist Circumference) ≥ 90(men), WC ≥ 85(women) * Able to give informed consent
Exclusion criteria
* Significant variation in weight(more 10%) in the past 3 months * Allergic or hypersensitive to any of the ingredients in the test products * History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery * History of alcohol or substance abuse * Participation in any other clinical trials within past 2 months * Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study * Pregnant or lactating women etc.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in Body Fat Mass | 12 weeks | Body Fat Mass was measured in study visit 1(0 week) and visit 3(12 week). |
| Changes in Percent Body Fat | 12 weeks | Percent Body Fat was measured in study visit 1(0 week) and visit 3(12 week). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in weight | 12 weeks | Weight was measured in study visit 1(0 week) and visit 3(12 week). |
| Changes in BMI(body mass index) | 12 weeks | BMI(body mass index) was measured in study visit 1(0 week) and visit 3(12 week). |
Countries
South Korea